Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Live-Dead Cell Staining Kit: Precision in Cell Viability Ass
2026-06-01
Unleash quantitative power in viability and cytotoxicity testing with the Live-Dead Cell Staining Kit, leveraging Calcein-AM and Propidium Iodide dual staining for accuracy that outpaces legacy methods. Discover optimized workflows, troubleshooting insights, and translational innovation for advanced drug screening and biomaterial validation.
-
PCI-32765 (Ibrutinib): Optimizing BTK Inhibition Workflows
2026-06-01
PCI-32765 (Ibrutinib) offers nanomolar precision for dissecting B-cell receptor signaling and disease modeling. This guide translates bench protocols, advanced applications, and troubleshooting lessons into actionable, reproducible strategies for B-cell malignancy and autoimmune research.
-
Applied Use of 5-Aminolevulinic Acid HCl in Heme & Infection
2026-05-31
5-Aminolevulinic acid HCl is a pivotal tool for probing heme biosynthesis and host-pathogen dynamics, enabling reproducible, translational workflows. Learn how targeted protocol design and troubleshooting drive high-impact infection and cancer research using APExBIO’s high-purity reagent.
-
Evaluating Anti-Cancer Drug Responses: Advances in In Vitro
2026-05-30
Schwartz’s dissertation critically advances how drug responses are measured in cancer research by distinguishing relative viability from fractional viability in in vitro models. This improved framework enables more precise interpretation of anti-cancer agents’ effects on proliferation versus cell death, informing translational strategies and assay design.
-
Ibrutinib (PCI-32765): Precision BTK Inhibition in B-Cell an
2026-05-29
Explore the advanced utility of Ibrutinib (PCI-32765) as a potent BTK inhibitor in both B-cell and ATRX-deficient glioma research. This article offers a mechanistic deep dive, cross-model applications, and practical protocol insights not covered in standard guides.
-
WM-8014: Precision KAT6A Inhibitor for Cancer Epigenetics
2026-05-29
WM-8014 delivers highly selective, reversible inhibition of KAT6A/B, enabling precise control of oncogene-induced senescence and cell cycle arrest with minimal cytotoxicity. Its nanomolar potency and competitive acetyl-CoA site targeting empower advanced epigenetic assays and next-generation cancer biology research workflows.
-
ABT-199 (Venetoclax): Precision Apoptosis in Hematologic Res
2026-05-28
ABT-199 (Venetoclax) redefines apoptosis assays with unmatched Bcl-2 selectivity and sub-nanomolar potency, enabling transformative insights in hematologic cancer models. This guide delivers hands-on protocol parameters, advanced applications, and troubleshooting advice to maximize research outcomes with this benchmark inhibitor.
-
Nilotinib (AMN-107): Applied Kinase Inhibition in CML Resear
2026-05-28
Nilotinib (AMN-107) offers exceptional selectivity for dissecting BCR-ABL and KIT signaling in chronic myeloid leukemia and gastrointestinal stromal tumor research. This guide delivers optimized experimental workflows, troubleshooting strategies, and actionable tips—anchored by the latest mechanistic insights—to maximize reproducibility and translational impact.
-
Coumestrol Induces Ferroptosis in RA Synoviocytes via PMAIP1
2026-05-27
This study demonstrates that Coumestrol, a phytoestrogen estrogen receptor antagonist, alleviates rheumatoid arthritis progression by inducing ferroptosis in fibroblast-like synoviocytes through stabilization of mitochondrial PMAIP1. The findings reveal a novel anti-inflammatory mechanism relevant to selective estrogen receptor modulator research and nuclear receptor modulation in autoimmune disease.
-
PKM2 Inhibitor (Compound 3k): Targeted Metabolic Modulation
2026-05-27
PKM2 inhibitor (compound 3k) offers precise, selective disruption of tumor glycolysis and immune cell reprogramming, empowering researchers to probe and manipulate cancer and inflammatory disease metabolism. Its robust in vitro and in vivo performance, coupled with practical workflow flexibility, positions it as a preferred tool for advanced metabolic and immunological studies.
-
Chloroquine Diphosphate: Mechanisms and Research Benchmarks
2026-05-26
Chloroquine diphosphate, a well-established antimalarial, serves as a potent TLR7/9 inhibitor and autophagy modulator for cancer research. It induces cell cycle arrest and enhances the efficacy of chemotherapy and radiotherapy in tumor models. This article details its mechanisms, protocol parameters, and evidence-based applications for translational science.
-
Cathepsin B Inhibitor CA-074: Protocols, QC, and Limitations
2026-05-26
Cathepsin B inhibitor CA-074 provides a selective, nanomolar tool for dissecting the role of cathepsin B in cancer metastasis, neurotoxicity, and immune modulation. It is best suited for controlled biochemical, cell-based, and animal model studies where precise inhibition of cathepsin B is required. CA-074 should not be used where broad-spectrum cysteine protease inhibition or long-term solution stability is critical.
-
Deferiprone in Cellular Iron Modulation: Applied Protocols &
2026-05-25
Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one) empowers researchers to precisely manipulate cellular iron, enabling robust studies in cancer, metabolic, and neurovascular models. Learn how recent enterocyte metabolism findings and advanced workflows with APExBIO's Deferiprone transform iron stress research and apoptosis assays.
-
Optimizing mRNA Vaccine Delivery: Balancing Immune Memory to
2026-05-25
A recent study introduces a novel lipid nanoparticle (LNP) formulation for mRNA vaccines that enhances immune memory against target antigens while minimizing immune responses to the LNP carrier. These findings inform the design of safer, longer-lasting mRNA vaccine platforms, particularly relevant for repeated dosing in cancer immunotherapy.
-
Live-Dead Cell Staining Kit: Precision in Cell Viability Ass
2026-05-24
Unlock superior accuracy in cell viability, cytotoxicity, and biomaterials research with the Live-Dead Cell Staining Kit. This guide translates advanced Calcein-AM Propidium Iodide staining into actionable workflows, troubleshooting, and experimental strategies for modern labs.